APA

Kumar P. N., Salvato P., LaMarca A., DeJesus E., Patel P., McClernon D., Florance A. & Shaefer M. S. (20090429). A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study). : AIDS research and therapy.

Chicago

Kumar Princy N, Salvato Patricia, LaMarca Anthony, DeJesus Edwin, Patel Parul, McClernon Daniel, Florance Allison and Shaefer Mark S. 20090429. A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study). : AIDS research and therapy.

Harvard

Kumar P. N., Salvato P., LaMarca A., DeJesus E., Patel P., McClernon D., Florance A. and Shaefer M. S. (20090429). A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study). : AIDS research and therapy.

MLA

Kumar Princy N, Salvato Patricia, LaMarca Anthony, DeJesus Edwin, Patel Parul, McClernon Daniel, Florance Allison and Shaefer Mark S. A randomized, controlled trial of initial anti-retroviral therapy with abacavir/lamivudine/zidovudine twice-daily compared to atazanavir once-daily with lamivudine/zidovudine twice-daily in HIV-infected patients over 48 weeks (ESS100327, the ACTION Study). : AIDS research and therapy. 20090429.